Novel SiRNA Development Based on the Key Technology Platform of Small Nucleic Acid Drugs
戚新明 中国科学院上海药物研究所副研究员
QI Xinming , Associate Professor, Shanghai Institute of Materia Mediaca, Chinese Academy of Science
10:00 - 10:20
项目4
Project 4
新型碱基编辑技术填补医疗需求空白,造福全球病患
Innovative Base Editing Technique Fulfills Unmet Medical Needs and Help Patients Worldwide
牟晓盾 正序(上海)生物科技有限公司首席执行官
Susan MOU , CEO, CorrectSequence Therapeutics
10:20 - 10:40
项目5
Project 5
从肠道微生物菌群出发,提供儿童孤独症谱系障碍疾病的防、检、诊、治、康复一体化解决方案
Starting from the Gut Microbiota, We Provide an Integrated Solution for the Prevention, Detection, Diagnosis, Treatment, and Rehabilitation of Autism Spectrum Disorders in Children
王硕 知几未来(成都)临床医学检验有限公司董事长
WANG Shuo , Chairman, Zhiji Future (Chengdu) Clinical Medical Laboratory Co.,Ltd.
10:40 - 11:00
项目6
Project 6
靶向液-液相分离的小分子药物研发
Development of Small Molecule Modulators Targeting Liquid-Liquid Phase Separation